Summary & Overview

CPT 11042: Debridement of Subcutaneous Tissue (first 20 sq cm)

CPT 11042 describes surgical debridement of subcutaneous tissue (including epidermis and dermis when performed) for the first 20 square centimeters or less. This code is a foundational entry for clinicians and billing teams managing wound care, limb-threatening infections, and ischemic ulcers where removal of nonviable subcutaneous tissue is required. It matters nationally because accurate coding drives appropriate clinical documentation, claim adjudication, and quality measurement for integumentary surgical procedures.

Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of when CPT 11042 is used clinically and operationally, how it relates to associated codes for additional surface area, and common administrative considerations that affect claim processing and coverage. The publication outlines typical coding relationships, common clinical indications tied to peripheral vascular and diabetic complications, and the context needed for appropriate code selection.

This summary prepares readers for detailed sections covering payer-specific policy language, documentation benchmarks, applicable diagnosis mappings, and code-to-code relationships that affect bundling and supplemental billing. Data not available in the input will be noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 11042DebridementWound careIntegumentary surgeryClinical documentationCoding guidanceProcedure definitions

CPT Code Overview

CPT 11042 covers surgical debridement of subcutaneous tissue, and includes the epidermis and dermis if performed; this entry applies to the first 20 square centimeters or less. The procedure is classified under Surgical — Integumentary system (Debridement Procedures on the Skin). Typical site of service: Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 62-year-old patient with long-standing type 2 diabetes presents with a chronic plantar foot ulcer with surrounding necrotic subcutaneous tissue and partial-thickness skin involvement. The wound care team evaluates the patient in an outpatient wound clinic. After assessment and conservative measures, the clinician performs surgical sharp debridement of devitalized subcutaneous tissue down to viable tissue, removing necrotic fat and nonviable subcutaneous debris over an area of 15 square centimeters. Hemostasis is achieved, wound measured and dressed, and the plan for ongoing wound care and vascular evaluation is documented. The procedure corresponds to debridement of subcutaneous tissue for the first 20 sq cm or less and is coded accordingly.

Coding Specifications

Modifier 59 (Distinct Procedural Service): Use when the debridement represented by 11042 is distinct from other procedures performed at the same session (for example, a separate unrelated surgical incision or another procedure at a different anatomic site). Documentation must support that the services are independent, not component parts of a more comprehensive service.
Modifier 76 (Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional): Use when the exact same debridement procedure 11042 is performed again by the same provider on the same day, for example if initial debridement was incomplete and a second debridement of the same area is performed later that day. Documentation must support the reason for the repeat service.
Associated Provider Taxonomies:

Taxonomy Code	Specialty
`207XS0106X`	Surgical Critical Care
`208600000X`	Surgery Physician
`207Q00000X`	Family Medicine Physician

These taxonomies represent clinicians who may perform or authorize debridement procedures on the integumentary system in different care settings.

Related Diagnoses

A48.0 — Gas gangrene

Relevance: Gas gangrene can present with extensive soft tissue necrosis requiring surgical debridement of subcutaneous tissues to remove devitalized tissue and control infection.
E08.51 — Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene

Relevance: Peripheral angiopathy in diabetes predisposes to chronic ulcers and nonhealing wounds where subcutaneous debridement may be necessary.
E08.52 — Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene

Relevance: Gangrenous changes from diabetic peripheral angiopathy often necessitate aggressive debridement of necrotic subcutaneous tissue.
E09.51 — Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene

Relevance: Similar to other diabetic peripheral angiopathies, this condition can lead to ischemic ulceration requiring subcutaneous debridement.
E09.52 — Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene

Relevance: Presence of gangrene in this context is an indication for removal of necrotic subcutaneous tissue.
E10.51 — Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene

Relevance: Ischemic complications of type 1 diabetes can produce nonhealing ulcers addressed by debridement of subcutaneous tissue.
E10.52 — Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene

Relevance: Gangrene associated with peripheral angiopathy often requires surgical debridement.
E11.51 — Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene

Relevance: Commonly associated with chronic lower-extremity ulcers where subcutaneous debridement is performed.
E11.52 — Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene

Relevance: Gangrenous changes in type 2 diabetes are a common indication for debridement procedures.
I70.231 — Atherosclerosis of native arteries of right leg with ulceration of thigh

Relevance: Limb ischemia with ulceration may require debridement of subcutaneous tissues to manage the wound.
I70.232 — Atherosclerosis of native arteries of right leg with ulceration of calf

Relevance: Ulceration of the calf related to atherosclerosis can necessitate subcutaneous debridement.
I70.233 — Atherosclerosis of native arteries of right leg with ulceration of ankle and foot

Relevance: Ankle/foot ulcers due to atherosclerosis commonly require removal of devitalized subcutaneous tissue.
I70.234 — Atherosclerosis of native arteries of right leg with ulceration of other part of foot

Relevance: Nonhealing foot ulcers may be managed with subcutaneous debridement.
I70.235 — Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg

Relevance: Lower-leg ulcerations often prompt debridement when necrotic subcutaneous tissue is present.
I70.238 — Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg

Relevance: See I70.235 — applicable when debridement of subcutaneous tissue is required.
I70.241 — Atherosclerosis of native arteries of left leg with ulceration of thigh

Relevance: Left-sided limb ischemic ulcers are indications for debridement when nonviable subcutaneous tissue exists.
I70.242 — Atherosclerosis of native arteries of left leg with ulceration of calf

Relevance: Calf ulceration due to atherosclerosis may be treated with subcutaneous debridement.
I70.243 — Atherosclerosis of native arteries of left leg with ulceration of ankle and foot

Relevance: Ulceration at the ankle/foot often requires removal of devitalized subcutaneous tissue as part of wound management.
I70.244 — Atherosclerosis of native arteries of left leg with ulceration of other part of foot

Relevance: Nonhealing foot ulcers on the left side may indicate need for debridement.
I70.245 — Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg

Relevance: Lower-leg ulceration on the left may require subcutaneous debridement.
I70.248 — Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg

Relevance: See I70.245 — applicable when debridement of subcutaneous tissue is required.
I70.25 — Atherosclerosis of native arteries of other extremities with ulceration

Relevance: Ulceration of other extremities due to atherosclerosis can necessitate debridement.
I70.261 — Atherosclerosis of native arteries of extremities with gangrene, right leg

Relevance: Gangrene presence is an indication for surgical debridement of necrotic subcutaneous tissue.
I70.262 — Atherosclerosis of native arteries of extremities with gangrene, left leg

Relevance: Left-leg gangrene commonly requires debridement to remove necrotic tissue.
I70.263 — Atherosclerosis of native arteries of extremities with gangrene, bilateral legs

Relevance: Bilateral gangrene necessitates debridement as part of limb salvage or infection control.
I70.432 — Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of calf

Relevance: Ulceration related to graft atherosclerosis may require debridement of subcutaneous tissue.
I70.433 — Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of ankle and foot

Relevance: Ankle/foot ulceration near bypass grafts can need subcutaneous debridement.
I70.434 — Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of foot

Relevance: Foot ulcerations near grafts may be managed with debridement.
I70.435 — Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg

Relevance: Lower leg ulcerations associated with bypass grafts often prompt debridement.
I70.438 — Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg

Relevance: See I70.435 — debridement may be required for nonviable subcutaneous tissue.

Related CPT Codes

CPT Code	Description	Relationship to `11042`
`11045`	Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); each additional 20 sq cm, or part thereof	Used when the debrided area exceeds the first 20 sq cm covered by `11042`; billed in addition to `11042` for additional increments of area.

Common use: 11045 is commonly reported in sequence with 11042 when total debridement area requires billing beyond the initial 20 sq cm. No other CPT codes were provided in the input.

National Reimbursement Benchmarks

National Medicare mean allowed rate ($137.50) sits between BUCA (average commercial) mean ($121.36) and the highest commercial payer, UnitedHealth Group ($167.24). BUCA’s mean is lower than Medicare, while several commercial payers (Cigna and UnitedHealth Group) exceed Medicare’s mean.

Dispersion measured as P75 minus P25 varies across payers. The tightest distributions are Medicare (range $16.00) and Aetna (range $44.47). The widest dispersions are UnitedHealth Group (range $102.67) and Cigna (range $95.10). The table and chart below present the full breakdown.

National Mean Allowed Rates for `11042` by Payer

Related Codes

11043

CPT 11043: Surgical Debridement of Muscle and Fascia

97597

CPT 97597: Active Wound Care Management, Selective Debridement (≤20 cm²)

97602

CPT 97602: Non-Selective Debridement, Active Wound Care Management

97605

CPT 97605: Negative Pressure Wound Therapy, ≤50 sq cm

12001

CPT 12001: Simple Repair of Superficial Wounds, ≤2.5 cm

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.